These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 17596915)
1. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Mu Q; Johnson K; Morgan PS; Grenesko EL; Molnar CE; Anderson B; Nahas Z; Kozel FA; Kose S; Knable M; Fernandes P; Nichols DE; Mailman RB; George MS Schizophr Res; 2007 Aug; 94(1-3):332-41. PubMed ID: 17596915 [TBL] [Abstract][Full Text] [Related]
2. A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. George MS; Molnar CE; Grenesko EL; Anderson B; Mu Q; Johnson K; Nahas Z; Knable M; Fernandes P; Juncos J; Huang X; Nichols DE; Mailman RB Schizophr Res; 2007 Jul; 93(1-3):42-50. PubMed ID: 17467956 [TBL] [Abstract][Full Text] [Related]
4. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex? Isacson R; Kull B; Wahlestedt C; Salmi P Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337 [TBL] [Abstract][Full Text] [Related]
6. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. Girgis RR; Van Snellenberg JX; Glass A; Kegeles LS; Thompson JL; Wall M; Cho RY; Carter CS; Slifstein M; Abi-Dargham A; Lieberman JA J Psychopharmacol; 2016 May; 30(5):428-35. PubMed ID: 26966119 [TBL] [Abstract][Full Text] [Related]
7. Dihydrexidine--the first full dopamine D1 receptor agonist. Salmi P; Isacson R; Kull B CNS Drug Rev; 2004; 10(3):230-42. PubMed ID: 15492773 [TBL] [Abstract][Full Text] [Related]
8. Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease. Blanchet PJ; Fang J; Gillespie M; Sabounjian L; Locke KW; Gammans R; Mouradian MM; Chase TN Clin Neuropharmacol; 1998; 21(6):339-43. PubMed ID: 9844789 [TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents. Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811 [TBL] [Abstract][Full Text] [Related]
10. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574 [TBL] [Abstract][Full Text] [Related]
12. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist. Darney KJ; Lewis MH; Brewster WK; Nichols DE; Mailman RB Neuropsychopharmacology; 1991 Nov; 5(3):187-95. PubMed ID: 1684499 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of D1 and D2 dopamine agonists on memory, motivation, learning and response time in non-human primates. Marino RA; Levy R Eur J Neurosci; 2019 Jan; 49(2):199-214. PubMed ID: 30326151 [TBL] [Abstract][Full Text] [Related]
14. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors. Salmi P; Ahlenius S Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951 [TBL] [Abstract][Full Text] [Related]
15. Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys. Schneider JS; Sun ZQ; Roeltgen DP Brain Res; 1994 Nov; 663(1):140-4. PubMed ID: 7850462 [TBL] [Abstract][Full Text] [Related]
16. Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine. Gleason SD; Witkin JM Psychopharmacology (Berl); 2006 May; 186(1):25-31. PubMed ID: 16575553 [TBL] [Abstract][Full Text] [Related]